[46B2-46B2];[46C7-46C7];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
46B2;46C7
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Lethal in combination with Df(2R)BSC133.
Inferred to overlap with: Df(2R)BSC131.
Inferred to overlap with: Df(2R)BSC133.
The presence of P+PBac{XP5.WH5}BSC298 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(2R)BSC298 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}CG1776f00802 and P{XP}Mef2d07371 transposable element insertions sites are 46B2;46C7.